The postoperative adjuvant radiation therapy and radiochemotherapy for UICC Stage II and III rectal cancer. A retrospective analysis

Strahlentherapie und Onkologie

Volumn 176, Issue 3, 2000, Pages 112-117

  Bagatzounis, Athanasios ^a   Willner, Jochen ^b   Oppitz, Ulrich ^b   Flentje, Michael ^b  

^a Bank of Cyprus Group Oncology Centre   (Cyprus)

^b B O Cyprus Oncology Center ^*

Author keywords

Adjuvant treatment; Radiochemotherapy; Rectal cancer

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; MALE; METASTASIS; POSTOPERATIVE CARE; PROGNOSIS; RECTUM CANCER;

EID: 0034097439     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00002335     Document Type: Article

References (52)

1. Adam I, Mohamed M, Martin I, et al. Role of circumferential resection margin involvement in the local recurrence of rectal cancer. Lancet 1994;344:707-11.
2. Arnaud J. Nordliger B, Bosset J, et al. Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase III study of the European Organisation for Research and Treatment of Cancer. Br J Surg 1997;84:352-7.
3. Balslev I, Pedersen M, Teglbjaerg P. Postoperative radiotherapy in Dukes B and C carcinoma of the rectum and rectosigmoid. A randomised multicentre study. Cancer 1986;58:22-8.
4. Blomqvist L, Rubio C, Holm T, et al. Rectal adenocarcinoma: Assessment of tumor involvement of the lateral resection margin by MRI of resected specimen. Br J Radiol 1999;72:18-23.
5. Brown G, Richards C, Dallimore N, et al. Rectal cancer: Thin slice MR staging to determine extramural spread. Radiology 1999;211:215-22.
6. Carlsen E, Schlichting E, Guldvog I, et al. Effect of the introduction of total mesorectal excision for the treatment of rectal cancer. Br J Surg 1998;85:526-9.
7. Cawthorn S, Parums D, Gibbs N, et al. Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet 1990;335:1055-9.
8. Chen E, Mohiuddin M, Brodovsky H, et al. Down-staging of advanced rectal cancer following combined preoperative chemotherapy and high-dose radiation. Int J Radiat Oncol Biol Phys 1994;30:169-75.
9. Church J, Raudkivi P, Hill G. The surgical anatomy of the rectum-a review with particular relevance to the hazards of rectal mobilisation. Int J Colorect Dis 1987;2:158-66.
10. Colon and rectum. In: American Joint Committee on Cancer: AJCC Cancer Staging Manual, 5th edn. Philadelphia: Lippincott-Raven, 1997:83-90.
11. Cox D. Regression models and life tables. J R Stat Soc B 1972;34:187-220.
12. Dahlberg M, Glimelius B, Graf W, et al. Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomised study. Dis Colon Rectum 1998;41:543-51.
13. Enker W. Total mesorectal excision - The new golden standard of surgery in rectal cancer. Ann Med 1997;29:127-33.
14. Fasolini F, Notter M, Ernli M, et al. Preoperative radiotherapy, total mesorectal excision and postoperative chemotherapy for T3 and T4 rectal cancer. Coloproctology 1999;21:50-6.
15. Fisher B., Wolmark N, Rockette H. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Nat Cancer Inst 1988;80:21-9.
16. Frykholm G, Glimelius B, Pahlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: Final treatment results of a randomised trial and an evaluation of late secondary effects. Dis Colon Rectum 1993;36:564-72.
17. Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 1985;312: 1465-72.
18. Gerard A, Buyse M, Nordlinger B, et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Ann Surg 1988;208:606-14.
19. Hall N, Finan P, Al Jaberi T, et al. Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence? Dis Colon Rectum 1998;41:979-83.
20. Heald R, Husband E, Ryall R. The mesorectum in rectal cancer surgery: The clue to pelvic recurrence? Br J Surg 1982;82:613-6.
21. Heald R, Karanija B. Results of radical surgery for rectal cancer. World J Surg 1992;16:848-57.
22. Hermanek P, Wiebelt H, Staimmer D, et al. and the German Study Group Colo-rectal Carcinoma (SGCRC). Prognostic factors of rectum carcinoma. Experience of the German Multicenter Study SGCRC. Tumori 1995;81:60-4.
23. Hill G, Rafique M. Extrafascial excision of the rectum for rectal cancer. Br J Surg 1998;85:809-12.
24. Horn, A, Halvorsen J, Dahl O. Preoperative radiotherapy in operable rectal cancer. Dis Colon Rectum 1990;33:823-8.
25. Hyams D, Mamounas E, Petrelli N, et al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: A progress report of NSABP R-03. Dis Colon Rectum 1997;40:131-9.
26. Kim N, Senagore A, Luchtefeld, et al. Adjuvant radiation therapy in resectable rectal cancer: Should local recurrence rates affect the decision? Am Surg 1997;63:579-85.
27. Köckerling F, Reymond M, Altendorf-Hofmann A, et al. Influence of surgery on metachronous distant metastases and survival in rectal cancer. J Clin Oncol 1998;16:324-9.
28. Kollmorgen C, Meagher A, Wolff B. The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function. Ann Surg 1994;220:676-82.
29. Krook J, Moertel C, Gunderson L. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709-15.
30. Kusunoki M, Yanagi H, Hishikawa Y, et al. Preoperative detection of local extension of carcinoma of the rectum using magnetic resonance imaging. J Am Coll Surg 1994;179:653-6.
31. Marks G, Mohiuddin M, Masoni L, et al. The reality of sphincter preservation surgery for cancer of the distal 3 cm of rectum following high dose radiation. Int J Radiat Oncol Biol Phys 1993;27:779-83.
32. Minsky B, Cohen A, Enker W, et al. Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer. Int J Radiat Oncol Biol Phys 1997;37:289-95.
33. Minsky B, Cohen A, Enker W, et al. Sphincter preservation with preoperative radiation therapy and coloanal anastomosis. Int J Radiat Oncol Biol Phys 1995;31:553-59.
34. MRC (Medical Research Council Rectal Cancer Working Party). Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Lancet 1996;348:1610-4.
35. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444-50.
36. O'Connell M, Martenson J, Wieand H, et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994;331:502-7.
37. Pahlman L, Hohenberger W, Günther K, et al. Current controversies in cancer. Is radiochemotherapy necessary in the treatment of rectal cancer? Eur J Cancer 1998;34:438-48.
38. Quirke P. Reporting protocols in colorectal cancer. Bull Cell Pathol 1999;1:58-64.
39. Quirke P, Durdey P, Dixon M, et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumor spread and surgical excision. Lancet 1986;2:996-8.
40. Rau B, Wust P, Gellermann J, et al. Phase-II-Studic zur präoperativen Radio-Chemo-Thermo-Therapie beim lokal fortgeschrittenen Rektumkarzinom. Strahlenther Onkol 1998;174:556-65.
41. Rich T, Skipper J, Jaffer J, et al. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 1995;32: 1025-9.
42. Rödel C, Hohenberger W, Sauer R. Adjuvante und neoadjuvante Therapie des Rektumkarzinoms. Aktueller Stand. Strahlenther Onkol 1998;174: 497-504.
43. Rouanet P, Fabre J, Dubois J, et al. Conservative surgery for low rectal carcinoma after high dose radiation: Functional and oncologic results. Ann Surg 1995;221:67-73.
44. Rouanet P. Sphincter preservation and low rectal carcinoma: interest for a prospective trial. Bull Cancer 1998;85:328-32.
45. Schutz G, Aleksic M, Ulrich B. Rectal cancer in a district general hospital: controlled follow-up study. World J Surg 1999;23:509-13.
46. Stockholm Rectal Cancer Study Group. Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomised trial. Cancer 1990;66:49-55.
47. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997;336:980-7.
48. Tannapfel A, Nuesslein S, Katalinic A, et al. Proliferation und Apoptose vor und nach präoperativer simultaner Radiochemotherapie von Rektumkarzinomen. Strahlenther Onkol 1998;174:295-9.
49. Tepper J, O'Connell M, Petron G, et al. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of Irtergroup 0114. J Clin Oncol 1997;15: 2030-9.
50. Treutniet-Donker A, van Puten W, Wereldsma J, et al. Postoperative radiation therapy for rectal cancer. Cancer 1991;67:2042-8.
51. Tveit K, Guldvog I, Hagen S, et al. Randomised controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Br J Surg 1997;84:1130-5.
52. Valentini V, Coco C, Cellini N, et al Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation. Int J Radiat Oncol Biol Phys 1998;40:1067-75.